Psychedelics, psychiatry and pharmacokinetics - where are we now?
Expert Opin Drug Metab Toxicol August 19, 2025 DOI: 10.1080/17425255.2025.2549987 (opens in new tab) via PubMed
Summary
AI-generated from the abstractClassical psychedelics are being explored as potential treatments for depression, anxiety, and addictions, differing from traditional psychiatric medications by their unique mechanisms of action. The text introduces their therapeutic promise but does not present a specific finding or result.
Study at a glance
| Characteristics | Peer reviewed |
|---|
Abstract
1. Classical psychedelics are gaining attention as potential treatments for a range of neuropsychiatric conditions, including depression, anxiety, and addictions [1]. Psychedelics differ from tradi...